News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Flechtner Jessica Baker
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Sold 1,212 shares
@ $1.25, valued at
$1.5k
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 8,365 shares
@ $0
Granted 31,500 options to buy
@ $2.72, valued at
$85.7k
|
|
| 04/06/2020 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 15,536 shares
@ $0
Granted 58,500 options to buy
@ $1.66, valued at
$97.1k
|
|
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2018 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 150,000 options to buy
@ $0.73, valued at
$109.5k
|
|
| 06/25/2018 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 162,500 options to buy
@ $0.98, valued at
$159.3k
|
|
| 02/12/2018 |
4
| Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 137,500 options to buy
@ $0.98, valued at
$134.8k
|
|
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|